Last reviewed · How we verify
BA058 80 µg
At a glance
| Generic name | BA058 80 µg |
|---|---|
| Sponsor | Radius Health, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption (PHASE3)
- Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |